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Abstract
Cardiovascular magnetic resonance (CMR) imaging is a preferred imaging methodology due to its
lack of ionizing radiation and ability to detect myocardial inflammation and fibrosis using
quantitative T1 mapping techniques. Cardiac sarcoidosis (CS) is characterized as the formation of
granulomas in the myocardium. Current methods for detection include measuring non-cardiac
specific C-reactive protein (CRP) levels, or PET imaging, which uses ionizing radiation, therefore
CMR would make an ideal imaging option. However, many CS patients have implanted cardiac
devices which can cause degradation in image. The modified Look-Locker inversion recovery
(MOLLI) method is widely used in quantitative T1 mapping with high precision but low accuracy
and susceptibility to artifact. Newer methods like saturation recovery single-shot acquisition
(SASHA) may be less susceptible to field inhomogeneities but have yet to be compared directly
to MOLLI in CS patients with implanted devices. T1-values can further be affected by how the
signal data is compiled, or their readout. Common readouts include balanced steady-state free
precession (TRUFI) and fast low angle shot (FLASH).
First, SASHA sequences provided more consistent images that can be used for diagnostic purposes
while MOLLI varied between extreme image quality categories. Finally, SASHA techniques in
general show lower variability while GRE readouts suggest higher reproducibility between
multiple scans. Through this sub-analysis study, SASHA TRUFI, MOLLI TRUFI, SASHA
FLASH, and MOLLI FLASH sequences were optimized to move forward with primary studies of
CS patients in the MRI field.
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1

Background
1.1 Introduction to Cardiac MRI

Magnetic resonance imaging (MRI) is on the forefront of imaging modalities. MRI manipulates
the abundance of positive protons from water in the human body to create detailed images of
organs and tissues. Patients are placed in a powerful magnetic field to be scanned in the range of
1-3 Tesla (T) whereas the Earth’s natural magnetic field is around 30uT (1).
While inside the machine, protons within the body are aligned parallel to the magnetic field B0. A
gradient coil can be used to produce a linear variation of the magnetic field known as B1. Radio
frequency (RF) pulses, typically 90 degrees, are applied to the area of interest to disrupt the aligned
protons. When the protons revert to their magnetized positions, they release radio signals that are
picked up by receivers (1, 2).
Directly after the RF pulse is the peak of the transverse signal. At about 1/3 of the peak is known
as the T2 relaxation time as described in Equation 1. This is also known as the T2 decay value as
the function decreases exponentially (3).
−𝑡

𝑀𝑥𝑦 (𝑡) = 𝑀0 𝑒 𝑇2
Equation 1. T2-decay.

Longitudinal recovery that begins after the excitation pulse is described by Equation 2. The T1
relaxation time is characterized by about 2/3 of full recovery (3).
𝑡

𝑀𝑧 (𝑡) = 𝑀0 (1 − 𝑒 −𝑇1 )
Equation 2. T1-relaxation.
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The time for recovery along the z-axis is known as T1 or longitudinal relaxation time. The
relaxation time from the x- and y-axis are known as T2 or transverse relaxation times.
MRI is shown to capably differentiate between soft tissues by taking advantage of the ranges of
T1 and T2 values, especially those involved in the heart. Approximate T1 values at 1.5T for fat
and water are 260ms and 4000ms respectively. T2 values for fat and water are approximately 80ms
and 2000ms (1). Without any enhancement, these are known as native T1 and T2 values. Similarly,
healthy myocardial tissue will have different T1 and T2 properties than pathologic myocardial
tissues allowing for quantitative analysis (4, 5).
Cardiovascular magnetic resonance (CMR) imaging is specifically designed to analyze pathology
and morphology of the heart. This includes but is not limited to tissue characterization, blood flow,
and myocardial perfusion. CMR is particularly useful in diagnosis of the heart including
cardiomyopathies, like scarring of the heart, compared to other imaging modalities such as x-ray,
positron emission tomography/computed tomography (PET/CT), or fluoroscopy (1, 6). This is in
part due to the use of magnetic fields and RF pulses in CMR as compared to harmful ionizing
radiation that may result in burns, genetic damage, or increase in risk projection (1, 7, 8).

1.2 Introduction to Cardiac Sarcoidosis
Myocardial tissue can be affected by a variety of pathologies. Inflammation of the heart muscle,
or myocarditis, can affect the heart’s ability to pump blood in response to viral infections (9, 10).
Another inflammatory disease is cardiac sarcoidosis (CS): the development of granulomas or
inflammatory cells in the body. Current surveillance methods include monitoring the C reactive
protein (CRP) which is a non-cardiac specific marker of inflammation. Other imaging modalities
like PET/CT use low doses of radiation put into the patient’s body. This process may be expensive
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and difficult to prepare for. Constant exposure to radiation may lead to long term adverse health
effects like cancer or cardiovascular disease. Identification of myocardial inflammation and
scarring due to CS is extremely important as they can lead to complications further in life.
Thickened myocardium makes it harder to pump blood as the tissue loses its elasticity. Abnormal
heart rhythms are especially alarming and need to be addressed. Cardiac edema is characterized
by swelling of the heart. Excess fluid, in this case blood, builds up in the right ventricle, causing it
to swell and decrease overall blood (11, 12). Another case to consider is myocardial scarring. This
is an accumulation of fibrosis tissue due to disease or trauma. The result from an injury where
necrotic tissue transforms in fibromas are fibrosis. With the myocardium inflamed, the tissue
becomes thicker and less elastic. This may result in reduced function of the heart leading to
shortness of breath, fatigue, and arrhythmias (13-17).
Cases where scarring and inflammation are detected are typically given steroids as treatment.
While steroids are effective at reducing inflammation, many other side effects due to long term
use such as reduced immune response, muscle weakness, and mood swings (18, 19). Scar is found
to be directly related to major adverse cardiovascular effects. Detection and quantification of the
extent of myocardial scarring is important in early prognostic scans in addition to monitoring
changes in current clinical management. While focal fibrosis may be easier to detect, it is the
diffuse fibrosis that is more commonly overlooked (16, 17, 20, 21). In addition, diagnostic quality
of scans can be inhibited by cardiovascular implantable electronic device (CIED) artifact.
CMR provides high spatial resolution, ability to assess normal myocardial wall thickness, and
show the spread of nonviable myocardium within the heart. Above all, MRI is non-ionizing
compared to other imaging modalities and painless compared to biopsy or surgery.
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1.3 Current Methods and Short Comings for the CMR Assessment of Myocardial Scar
1.3.1 Late-Gadolinium Enhancement
To better characterize tissue, contrast agents like gadolinium are often administered to help better
differentiate visually between normal and abnormal tissues by shortening T1 values. Gadolinium,
a water-soluble, extracellular based contrast agent, is given to the patient and diffuses throughout
the tissues providing high contrast in the extracellular volume and accumulates in other areas like
interstitial fibrosis. The contrast agent accumulates in the proliferated fibroblasts therefore
enhancing pathologies, visual contrast, and shortening T1 recovery time. Patients are placed in the
scanner and given the contrast agent intravenously. After 5 to 10 minutes, late gadolinium
enhancement (LGE) acquisition begins (22). LGE is considered the gold standard MRI sequence
for identifying myocardial inflammation and focal fibrosis. Well-established LGE techniques are
single shot (SS) or phase-sensitive inversion recovery (PSIR). SS is a technique where all data is
acquired after a single 90-degree excitation pulse. PSIR is a common sequence offered by many
MRI vendors that preserve the polarity of the longitudinal component of magnetization (1). These
are images taken in one breath-hold if allowed by patient capabilities.
Patients usually referred for CMR typically have lower cardiac function, and therefore introduce
many artifacts via motion during the scanning process or having an implanted device producing
off-resonance artifacts. Overall, LGE sequences are not well equipped to deal with artifacts in
images due to magnetization or implanted devices. LGE is also not entirely able to capture diffuse
fibrosis for useful diagnostic value. In a study by Abdel-Aty et al., only 71% of LGE scans had
diagnostic accuracy out of 25 patients suspected to have acute myocarditis (6). In another study to
assess myocardial scar in patients with cardiovascular implanted devices, only 78% of scans were
determined to be diagnostic (23).
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To combat high frequency artifacts caused by things such as implanted devices, a wideband LGE
(WB LGE) sequence was developed by increasing the spectral bandwidth of the RF pulse in
traditional LGE to account for the frequency shifting of surrounding tissue. Typically, the spectral
bandwidth is increased from 1.1kHz to 2-6kHz. The larger frequencies are typically those occupied
by off resonant artifact due to CIEDs near the heart. WB LGE comparisons to traditional LGE are
stark especially in patients with cardiac devices. Although there is resounding success in removing
off-resonant artifact, it is still subject to partial image voids due to device leads, geometric
distortions, and motion artifact.
In contrast to a previous study where 32% of traditional LGE scans were non-diagnostic, 100% of
scans done with WB LGE were found to be without severe artifact where 79% of the patients had
implanted defibrillators. This study also changed medical management in 49 out of 113 patients
who previously only had traditional LGE scanning sequences (23). WB LGE has also shown to
remove artifact from 87% (n=22) scans using a free-breathing motion-corrected (MOCO)
sequence (24). Images with persisting hyper-enhancement artifact with standard LGE images had
their artifact score reduced with WB LGE in 21 out of 27 patients (25). Additionally, Stevens et
al. eliminated hyperintensity artifact in 16 of 18 patients using WB LGE (26). Importantly, despite
the success of WB LGE, it remains subject to the limitation of not identifying diffuse fibrosis.
Thus, quantitative T1 mapping methods are still needed to succinctly tell the difference between
diffuse and focal fibrosis.

1.3.2 Modified Look-Locker Inversion Recovery (MOLLI)
Due to limitations from qualitative traditional LGE, methods of quantitative T1-mapping began to
be developed and tested. One of the first techniques developed was the Look-Locker sequence
which involves taking images repeatedly after inversion pulses to get multiple images along the
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recovery curve. As an inversion recovery method, this completely magnetizes protons, and as they
precess to normal, images are taken at specific inversion times to create a recovery curve. As a
basic technique, it has some drawbacks including only apparent T1 values and in-plane and
through-plane motion artifacts. As a result, the modified Look-Locker inversion (MOLLI)
recovery method was derived. Rather than a qualitative assessment, this quantitative T1-mapping
technique provides voxel-by-voxel T1 measurements. A widely used MOLLI sequence is a 5(3)3
sequence: 180-degree RF pulse followed by 5 images taken across 5 heart beats at varying
inversion times afterwards a 3-heartbeat rest, another 180 degree pulse, and 3 more images taken
at offset inversion times. This builds a recovery curve for each pixel of an image and results in a
T1 map. MOLLI has been extensively studied and used in clinical settings. The sequence is known
to have high precision and reproducibility. Although generally involving undervalued T1 values,
MOLLI has been useful in assessing both focal and diffuse myocardial fibrosis. To reduce scan
time and patient time in the magnet, a shortened MOLLI (shMOLLI) sequence was developed.
The shMOLLI sequence decreases the breath hold time to 9 heartbeats. As expected, motion
artifact is significantly reduced compared to standard MOLLI. Although as its foundations are still
an inversion recovery, it is still susceptible to the same drawbacks of MOLLI.
Although generally high in image quality, there are still disadvantages to the inversion recovery
methods. MOLLI is shown to have high dependence on T2 values, magnetization transfer (MT),
and inversion efficiencies. Studies have shown that MT decreases measured T1 by 10% or greater.
MT is the result of applied RF pulses to the interaction of bound proton pools spilling into the free
water pool. Inversion efficiencies have been shown to be a source of T1 error as the pulses do not
fully excite the area of interest. The conventional steady-state free precession (SSFP) readout of
MOLLI-based methods is also highly susceptible to off-resonant errors in T1 values.
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1.3.3 Saturation Recovery Single-Shot Acquisition
In contrast, there are saturation recovery methods that have been recently introduced for MRI and
CMR uses. A saturation recovery (SR) method involves taking a single signal measurement at
different inversion times across different heartbeats. A saturation recovery single-shot acquisition
(SASHA) is a relatively new quantitative T1-mapping technique with potential in more clearly
identifying myocardial inflammation and scar. SASHA and most SR methods use a 90-degree RF
pulse after which a signal is recorded at a certain inversion time. This is repeated seven more times
at increased inversion times across separate heartbeats to create a T1 curve. Saturation recovery is
beneficial since it needs no correction for underestimated T1 values. The 90-degree pulse allows
for a more direct estimate of T1 since the magnetization memory is erased from prior cycles.
SASHA is known to have higher accuracy but lower precision. SASHA is also found to be more
prone to noise artifact. Due to its lower precision, there is a lower reproducibility but consistent
accuracy (
Figure 1).
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Figure 1. Comparison of T1-mapping sequences including MOLLI, shMOLLI, SASHA, and
Saturation Pulse Prepared Heart-Rate Independent Inversion Recovery (SAPPHIRE).

1.4 Gradient Echo Sequence Readouts
Images obtained using CMR have a variety of readout methods after collecting the data from the
RF data. Inside the main magnet are three gradient coils which produce the magnetic field, B0.
The gradient echo (GRE) is produced by using a single RF pulse in one direction and then reversed,
resulting in an echo. By using one RF pulse, it reduces scan time compared to other basic pulse
sequences, like spin echo, therefore forming the basis of most standard rapid MRI sequences. After
the initial excitation, the resulting gradient begins to de-phase. When the reversal is applied, the
gradient will begin to rephase. (1, 27).
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Flip angles are defined as the angle in which the longitudinal vector is displaced from equilibrium.
Large or small flip angles create large or small transverse magnetization, respectively. For rapid
sequences, a smaller flip angle is desired as they are crucial in determining tissue contrast in GRE
sequences (1). GRE imaging requires strong field homogeneities. It is important to note that GRE
can only refocus spins that have also been rephased by that same gradient therefore more highly
affected by field inhomogeneities that affect the phasing.

1.4.1 Balanced Steady-State Coherent Gradient Echo
One type of GRE sequence is the balanced steady-state free precession (bSSFP) coherent sequence
Balanced indicates that the net gradients are zero or are fully rephased before the next excitation
pulse. Coherent GREs broadly imply that no transverse magnetization from the reversal gradient
remains (28, 29). The signal intensity resulting from the coherent sequence comes to be a ratio of
T2/T1. For solid tissues like muscle and fat, the ratio is low, 0.05 and 0.30, respectively. Fluids
demonstrate a higher ratio upwards of 0.70 creating an excellent base for CMR imaging (28, 30,
31). The higher signal to noise ratio (SNR) provides good contrast in T1 images and potentially
reducing noise from CIED artifact. Common trade names for this kind of sequence include: True
FISP (TRUFI) (Siemens), FIESTA (GE), True SSFP (Toshiba), and Balanced FFE (Phillips). For
consistency, the remainder of this report will be using Siemen’s tradenames representing bSSFP.

1.4.2 Incoherent “Spoiled” Gradient Echo Sequence
In contrast, there is also an incoherent, “spoiled” gradient echo sequence. Compared to coherent
sequences, incoherence deals with residual transverse magnetization that may be the result of small
flip angles. The successive signals “spoiled” by including a phase shift as the receiver can
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distinguish the phases from previous, successive RF pulses. As a result, T1-weighted images are
generated with little to no T2 dependence with typically moderate to large flip angles.
Common trade names for this sequence include: FLASH (Siemens), MPGR (GE), and Field Echo
(Toshiba). For consistency, an incoherent “spoiled” gradient echo will be referred to by Siemen’s
tradename, FLASH.

1.5 Degradation in Diagnostic Image Quality Due to Implanted Cardiovascular
Electronic Devices in Cardiac Sarcoidosis Patients
The aim of medical imaging is to obtain diagnostic scans free of artifact and without substantial
degradations in imaging. In CMR, it is especially important to be able to have high contrast images
of the myocardium with adequate spatial resolution to visualize smaller details of the heart. Any
potential distortions, small or large, may gravely affect the clinical value of the scan.
In recent years, the safety of patients with implanted devices have been taken into consideration
for MRI. Devices are marketed as MR conditional, MR safe, and MR unsafe. While the latter
option poses a hazard to the highly magnetic environment, the first two options can be safely
scanned within the patient (32). Although they are marked as such, it does not mean that they will
not induce off-resonant artifact onto the image from the magnetic field interacting with the ferrous
metal of the device and its components. Patients with potential myocarditis and other diseases with
high scar burden (and thus arrhythmogenic potential) may already have CIED in order to prevent
arrhythmias and sudden cardiac death. With the device in mind, potential artifact from the devices
can affect patient scans. Leads from devices like pacemakers can create voids in the atrium,
ventricle, or both depending on the necessary placement. The generator box placement is a bit
bulkier, typically placed subcutaneously below the left clavicle. This can introduce even larger
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voids in CMR scans and off resonant artifact. One way to combat the artifact surrounding the heart
is to physically move it. Technicians have the patient lift their arm above their head and keep it in
place for the scan. This can potentially move the artifact away from the myocardium enough for
diagnostic quality. In some cases, this may be sufficient but having the patient maintain this
position can be laboring and introduce other complications to the process.
Another difficulty in CMR is the differentiation between focal and diffuse myocardial fibrosis.
While focal fibrosis is concentrated and easily distinguished in LGE images, diffuse fibrosis is
more difficult to detect as it is spread out and patchy. Diffuse fibrosis is prominent in patients
diagnosed with CS (33). Patients with CS are typically recommended to have a CIED to assist with
any resulting cardiac complications such as arrhythmias or sudden cardiac death. While WB LGE
has shown promise in allowing diagnostic imaging of patients with focal fibrosis, diagnostic T1
mapping could potentially capture subclinical changes in pathology including inflammation and
fibrosis.
In addition to artifact introduced by CIED, the difficulty in identifying diffuse scarring and
inflammation becomes even more challenging. Native T1-mapping is non—specific to scar unless
contrast is given. Combination of T1 and T2-quantitative mapping may improve diagnostic
accuracy and identification of inflammation and scar (34). Cardiac sarcoidosis patients require a
better way to identify diffuse scar and safely monitor the extent and progression of the disease.
There is a disparity for imaging sarcoidosis patients with CIEDs. Imaging modalities like PET/CT
require ionizing radiation while current CMR standard sequences are not fully capable of acquiring
artifact-free images due to the challenging circumstances.
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While certain MRI techniques like LGE and MOLLI have been well established and researched,
saturation recovery methods like SASHA have yet to be fully explored. SASHA may have the
potential to overcome CIED artifact in cardiac sarcoidosis patients while preserving or enhancing
image quality for diffuse scar in the myocardium.

1.6 Specific Aims and Objectives
The specific objectives of this research are to confidently measure T1 values by comparing
myocardial images of cardiac sarcoidosis patients with implanted devices taken with different
sequences (MOLLI and SASHA) and readouts (FLASH and TRUFI) resulting in four separate T1
mapping sequence combinations.
Aim 1: Determine image quality of scans using MOLLI and SASHA protocols with
varying readouts, TRUFI and FLASH, in patients with sarcoidosis and CIEDs using a 5point scale: 5 (excellent), 4 (good), 3 (fair), 2 (poor), and 1 (non-diagnostic).
Hypothesis 1: SASHA with a FLASH readout will have higher image quality
scores due to less susceptibility to off-resonant artifacts from CIEDs.
Aim 2: Determine the variance and reproducibility between quantitative T1 mapping
sequences MOLLI and SASHA with varying readouts, TRUFI and FLASH, in cardiac
sarcoidosis patients with devices.
Hypothesis 2: The SASHA method with a FLASH readout will show little to know
discrepancy between initial and secondary exams due to those methods being less
susceptible to field inhomogeneity.
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High overall image quality score with reproducible quantification will indicate which
imaging protocol is best suited to scan patients with CIED artifact for diagnostic value.
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2 Quantitative T1-Mapping and Analysis
2.1 Rationale and Hypotheses
Current imaging modalities and methods are not properly addressing the needs of patients with
sarcoidosis and CIEDs. Modalities like PET/CT, x-ray, and fluoroscopy all use low dosage
ionizing radiation. Although not immediately a danger, constant exposure may pose adverse health
effects. LGE and WB-LGE have shown to be useful in imaging focal scarring but not diffuse scar
in patients with cardiac sarcoidosis and implanted devices. On top of well-recorded device artifact,
LGE particularly does poorly in distinguishing diffuse scar due to needing a myocardial reference
to find the difference between signal intensity. Diffuse fibrosis does not have well defined edges
for effective detection. Widely used inversion recovery methods like MOLLI also have three key
issues. First, MOLLI has shown to have a T2 dependence. Studies have shown phantoms with
shorter T2, in the 46ms to 76ms range, greatly underestimate T1 values. This trend is seen in-vivo
with even greater underestimation. In simulation, underestimations were also inconsistent. Second,
MOLLI has also shown high dependence on magnetization transfer as signals from the free pool
protons are mixed with the intracellular bound pool. Due to the summation of Look-Locker
sequences in MOLLI, the effect of MT for each image is compounded and cumulatively
contributes to underestimations of T1 values. Finally, MOLLI has shown to have imperfect
inversion efficiency. One study suggests a correction of 14.0+/- 6.6% to estimate a true T1 from
conventional MOLLI sequences following trends determined from other tissue (35).
While certain MRI techniques like LGE and MOLLI have been well-established and researched,
saturation recovery methods like SASHA have yet to be fully explored. SASHA may have the

Page 25 of 63

potential to overcome CIED artifact in cardiac sarcoidosis patients while preserving or enhancing
image quality for diffuse scar in the myocardium.

2.2 Methods
2.2.1 Study Design
This study is a sub-analysis for the Feasibility Phase of Cardiac Sarcoidosis Multi-Center
Randomized Controlled Trial to quantitatively determine myocardial inflammation and scar in
cardiac sarcoidosis patients with implanted cardiac devices. Five patients with clinically active
sarcoidosis were recruited from the VCU Sarcoidosis Clinic. Interpreters were blinded and
randomized to ensure equal distribution of devices across studies. Inclusion criteria were based on
CS Heart Rhythm Society Diagnostic Criteria (36). This involved patients with one or more of the
following clinical findings: histological diagnosis from myocardial tissue, clinical diagnosis from
invasive and noninvasive studies, and no alternative explanation for clinical features. Patients with
implanted devices must be at least 6 weeks post-implantation. Exclusion criteria were as follows:
patient unwilling or unable to provide informed consent, patient has a contraindication to CMR or
severe claustrophobia, renal disease with creatinine > 1.5mg/dL, pregnancy, or breastfeeding. All
patients enrolled in the program provided written and witnessed informed consent following
Institutional Review Board of Virginia Commonwealth University approval. Scans consist of
global values and axial slice-based values for the basal, mid-cavity, and apical slices of the left
ventricle. Each slice was further segmented into 6 regions for segmental analysis.
Study participants were asked to come into the clinic to be scanned using the four combinational
sequences. They were then asked to be rescanned within two weeks after the initial scan.
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2.2.2 CMR Protocol
All five participants in this study underwent CMR imaging on a 1.5T Siemens Magnetom Aera
scanner (Malvern, PA). Participants’ left arm was placed above their head in order to physically
move the generator box – a technique done to minimize interfering CIED artifact in the myocardial
region. The Siemens’ Quantitative Cardiac Parameter Mapping (T1, T2, T2*, ECV) work in
progress (WIP) #1041B (VE11C) was used for mapping sequences. For consistency, the remainder
of this report will reference Siemens’ tradenames for all readouts. After localization of the heart,
the protocol applied four different T1 mapping sequences pre-contrast: A MOLLI 5(3)3 sequence
(which refers to 5 acquisition heartbeat, followed by 3 recovery heart beats, followed by 3 more
acquisitions) and 2-parameter SASHA sequence were used with varying readouts FLASH and
TRUFI with a 35-degree flip angle and 8mm slice thickness or 70-degree flip angle and 8mm slice
thickness, respectively. The FLASH readout sequence was added to the imaging protocol partway
into the study due to ongoing updates. Images were taken at the base, mid-cavity, and apical shortaxis positions of the heart using a 5-slice reference scout to ensure matched tissue characterization
localization between study visits. T2 maps were then recorded involving 3 T2 preparations at 0,
25, and 55ms with recovery periods of 4 seconds with varying readouts FLASH and TRUFI at the
base, mid-cavity, and apical slices with a 35-degree flip angle and 8mm slice thickness or a 70degree flip angle and 8mm slice thickness, respectively. Participants were then injected with
contrast (0.15 mmol/kg gadopentetate dimeglumine) and imaged again with a MOLLI 4(1)3(1)2
scheme and a 2-parameter fit SASHA with participants at a heart rate of 90 bpm or greater in the
same 3 slices as native T1 maps. Patients returned to the hospital for a repeat scan following the
same procedure after X weeks.
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2.3 Qualitative Analysis
The endocardial and epicardial analysis were done by the one researcher which were verified by
the principal investigator. Image segments were given an image quality score (IQS) from a predefined scale ranging from 1 (non-diagnostic), 2 (poor), 3 (fair), 4 (good), 5 (excellent) (37). Six
segments of each region, basal, mid-cavity, and apical, were graded according to the scale by a
single investigator.
This scale is sourced from previous studies by Kellan et al for uniform extracellular volume
fraction (ECV) maps. Table 1 contains the visual descriptions and written criteria for each IQS
(37).
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Table 1. Visual and written criteria for image quality scoring for quantitative T1-values.

Non-diagnostic

Poor

Fair

Good

Excellent

Criteria under the excellent

One of the criteria under

category were absent, or

excellent was absent, or

Myocardial borders were crisp

T1 values could not be measured

Inhomogeneities or geometric

geometric distortion was

geometric distortion were

and distinct from the blood pool

reliably anywhere in the

distortion affected greater than

present, or multiple regions had

present but not impacting the T1

with less than or equal to 1 pixel

myocardium.

50% of the myocardium.

inhomogeneity deemed to be

values, or there were small

of partial volume border and no

artifactual but affected less than

regions (10%) of inhomogeneity

noticeable geometric distortion.

50% of the myocardium.

in the myocardium.
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2.4 Quantitative Analysis
Quantitative analysis was done using commercially available software cvi42 by Circle
Cardiovascular Imaging (Calgary, AB). Epicardial and endocardial contours were manually drawn
and then verified by a second party with a 10% contour offset to ensure that the blood pool and
epicardial fat were excluded from the contours. Each slice of the myocardium was segmented into
6 regions following major coronary artery territories based on the American Heart Association
(AHA) 17-segment model (38). All T1 averages and standard deviations per region were
automatically calculated within the software and exported for statistical analyses.

2.5 Statistical Analysis
Statistical analyses were performed in MATLAB using their statistical toolkits and built-in
functions. Slices or segments deemed non-diagnostic were excluded from the statistical analysis.
A paired t-test was applied between patients’ T1-values from their initial and secondary visits to
determine any scan-to-scan variation at a 95% confidence level.
An analysis of variance (ANOVA) test was conducted on the T1 values between SASHA and
MOLLI scans and then all four methods: SASHA TRUFI, SASHA FLASH, MOLLI TRUFI, and
MOLLI FLASH. The significant p-value was recorded at a 95% confidence level. An ANOVA
test was used to determine if the variance in means of the data was statistically significant.
A Tukey-Kramer post hoc test was performed on statistically significant results from the ANOVA
to determine a statistically significant pairs within the group. Finally, a coefficient of variation
(CoV) measurement was done between T1 values to determine relative dispersion.
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Due to the natural difference in inversion recovery and saturation recovery methods where the
former leads to underestimation and lower T1 values, the delta of the data was analyzed when
appropriate.

2.6 Results
Participants were mainly middle-aged women with an average of 35.4 months since CS diagnosis.
The time range between CMR examinations were extended due to SARS-CoV-2 pandemic
restricting patient travel and clinical operation (Table 2). Out of five patients, one patient’s scan
was severely impacted by artifact and was not included in the analysis (Figure 2).
Table 2. Patient demographic and characteristics.

Clinical Characteristics

N

Women, n (%)

4 (80%)

Race, n (%)
Black

3 (60%)

Caucasian

2 (40%)

Mean age, years

41 (range 38-61)

Time since CS diagnosis, months

35.4 (range 38-53 months)

Time between CMR examinations, days

19.25 (range 1-64 days)

Device type, n (%)
Boston Scientific

3 (60%)

Medtronic

2 (40%)

Page 31 of 63

Figure 2. Localizer scan with severe artifact for participant two. As a result, participant two was not included in analysis.

2.6.1 Determination of Image Quality Between Methods
Image quality scores from each segment of scans were tabulated in and used to calculate an average
for the entire region. In a slice-based analysis, 92.86% of regions scanned with SASHA were
scored above a poor rating while 83.33% of regions scanned with MOLLI were scored fair or
better (Figure 3, Figure 4).
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Regional Image Quality Score Distribution
Non-diagnostic
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%

Poor

Fair

Good

14%

Excellent

19%

31%
62%
33%
17%
17%

7%
SASHA

MOLLI

Figure 3. Image quality score distribution between SASHA and MOLLI scans of the heart. Slice-based scores were averaged
from segmental scoring in pre-contrast scans.

Regional Image Quality Score Distribution
Among Four Methods
Non-diagnostic

Poor

Fair

Good

Excellent

1.2
1
0.8
0.6

43%

0

47%

71%

0.4
0.2

33%

43%

50%

13%
20%

17%
13%

14%

SASHA TRUFI

MOLLI TRUFI

17%
0%
SASHA FLASH

20%
MOLLI FLASH

Figure 4. Distribution of slice-based image quality scores among the four methods: SASHA TRUFI, MOLLI TRUFI, SASHA
FLASH, and MOLLI FLASH in pre-contrast scans.
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Furthermore, within SASHA, 87.50% of regions (n=24) with a TRUFI readout were deemed fair
or better while 100% of regions (n=18) with a FLASH readout were evaluated to be fair or better.
Within MOLLI scans, 85.71% of regions (n=21) with a TRUFI readout were scored fair or better
with 0% of regions being excellent. 80.00% of FLASH slice-based readouts (n=15) with MOLLI
were scored above a poor rating.

2.6.2 Analysis of Native T1-Values
As shown in Table 3, MOLLI T1-values were generally lower than SASHA T1-values. Values are
given for the entire scan and then for each slice.
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Table 3. Global and slice-based coefficient of variance and T1-values (ms) for all participants for the basal (B), mid-cavity (M), and apical (A) slices.

SASHA
TRUFI
FLASH
TRUFI

FLASH

TRUFI

Global

B

M

A

Global

B

M

A

0.24
(1245 ± 299)
0.22
(1251 ± 273)
-

0.27
(1257 ± 339)
0.13
(1198 ± 158)
-

0.20
(1202 ± 238)
0.23
(1240 ± 291)
-

0.23
(1277 ± 296)
0.25
(1328 ± 334)
-

0.37
(695 ± 259)
029
(859 ± 252)
-

0.21
(654 ± 269)
0.37
(801 ± 293)
-

0.17
(592 ± 202)
0.29
(851 ± 249)
-

0.16
(879 ± 210)
0.15
(950 ± 144)
-

-

-

-

-

-

-

-

-

Visit 1

0.45
(1094 ± 491)
0.29
(1179 ± 339)
0.27
(1157 ± 317)

0.73
(464 ± 339)
0.66
(634 ± 419)
0.62
(709 ± 437)

0.69
(355 ± 246)
0.54
(618 ± 331)
0.65
(663 ± 432)

-

-

-

-

Visit 1

0.29
(1245 ± 363)
0.28
(1168 ± 324)
0.29
(1251 ± 363)

0.51
(886 ± 449)
0.35
(1234 ± 436)
0.30
(1115 ± 330)
0.16
(1146 ± 189)
0.41
(1291 ± 527)
0.20
(1164 ± 234)
0.41
(1304 ± 537)

0.48
(687 ± 332)
0.64
(609 ± 388)
0.46
(965 ± 442)

1157 ± 276

0.48
(1098 ± 529)
0.23
(1137 ± 261)
0.25
(1239 ± 313)
0.24
(1296 ± 249)
0.21
(1213 ± 281)
0.36
(1117 ± 398)
0.21
(1217 ± 252)

0.37
(515 ± 340)
0.63
(619 ± 388)
0.58
(792 ± 457)

Visit 2

0.36
(1222 ± 442)
0.29
(1189 ± 340)
0.28
(1159 ± 322)
0.27
(1166 ± 321)
0.17
(1228 ± 213)
0.24
(1220 ± 292)
0.18
(1234 ± 225)

-

-

-

-

0.28
(829 ± 236)
0.50
(720 ± 356)

0.25
(943 ± 236)
0.35
(697 ± 245)

0.20
(804 ± 159)
0.43
(674 ± 288)

0.34
(708 ± 237)
0.64
(806 ± 515)

0.13
(1143 ± 151)

0.11
(1140 ± 85)

0.09
(1127 ± 103)

0.19
(836 ± 156)

0.19
(858 ± 165)

0.21
(815 ± 173)

0.12
(833 ± 100)

0.86
(1182 ± 169)
0.30
(1229 ± 370)
0.90
(1161 ± 174)
0.09
(1177 ± 106)

0.68
(1168 ± 797)
0.33
(1165 ± 73)
0.77
(1157 ± 95)
0.08
(1153 ± 88)

0.40
(1230 ± 496)
0.14
(1075 ± 150)
0.48
(1260 ± 101)
0.09
(1211 ± 113)

0.24
(880 ± 208)
0.16
(918 ± 151)
0.13
(882 ± 115)
0.10
(876 ± 84)

0.23
(880 ± 198)
0.18
(921 ± 170)
0.13
(900 ± 121)
0.11
(860 ± 99)

0.29
(879 ± 252)
0.16
(897 ± 157)
0.14
(867 ± 118)
0.08
(883 ± 71)

0.14
(885 ± 121)
0.12
(944 ± 112)
0.10
(869 ± 87)
0.07
(895 ± 64)

Visit 1
Visit 2
Visit 1
Visit 2
Visit 1
Visit 2

Visit 2
Visit 1

FLASH

TRUFI

FLASH

MOLLI

Visit 2
Visit 1
Visit 2
Visit 1
Visit 2

0.11
(1137 ± 131)
0.22
(1188 ± 257)
0.30
(1172 ± 346)
0.13
(1184 ± 156)
0.09
(1177 ± 104)
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In comparison of slice-based values, MOLLI TRUFI showed significant difference in means
between initial (654±269ms) and secondary (801±293ms) visits (p-value=0.024) from a paired ttest while other methods did not show a significant change.
In a comparison of global values, there were no recorded statistically significant difference in
initial

and

secondary

Figure 5).
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scans

(
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Figure 5. Comparison of global initial and secondary T1-values across the four methods. Student's t-test p-value result is
reported.

Under an ANOVA test, global delta values for MOLLI and SASHA scans again did not suggest a
significant variance in the means of their respective data with a sample size of four. As there was
no significance, no post-host analysis was performed (Figure 6).
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25.00

Global ANOVA Test (p-value=0.069)

20.00

Average Δ T1 (ms)

15.00
10.00
5.00
0.00
SASHA TRUFI

SASHA FLASH

MOLLI TRUFI

MOLLI FLASH

-5.00
-10.00

Figure 6. Graphical representation of global ANOVA test done between SASHA TRUFI, SASHA FLASH, MOLLI TRUFI, and
MOLLI FLASH in pre-contrast scans.

Further analyses of slice-based T1 values suggest there are significant differences among the four methods
with a p-value=0.0184. A Tukey-Kramer post-hoc test was performed and determined that SASHA TRUFI
+ MOLLI TRUFI and SASHA FLASH + MOLLI TRUFI exceeded the critical value (qcrit) of 3.83 with 32
degrees of freedom (df) (Figure 7, Figure 8).

Slice-Based ANOVA (p-value=0.0184)
35
30

Average Δ T1 (ms)

25
20
15
10
5
0
-5

SASHA TRUFI

SASHA FLASH

MOLLI TRUFI

MOLLI FLASH

-10

Figure 7. Graphical representation of slice-based ANOVA results between SASHA TRUFI, SASHA FLASH, MOLLI TRUFI, and
MOLLI FLASH in pre-contrast scans.
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Figure 8. Tukey-Kramer results showing variations between the four methods and their q-values for native T1-values.

MOLLI CoV overall showed higher variability in relation to the average T1 values when compared
to SASHA methods in global T1 values. Under slice-based analysis, SASHA methods tend to have
a higher CoV specifically in the apical slices while MOLLI favored the basal and mid-cavity.
Global and slice-based TRUFI readouts had a higher variation compared to FLASH. Overall
MOLLI FLASH had the lowest CoV (Table 3).
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2.7 Discussion
In

Figure 5 there are no significant differences in initial and secondary visits. Deeper analysis of slice-

based values suggest MOLLI TRUFI may not be as reproducible as the other three methods (Figure
7). This result does not agree with current literature that suggests MOLLI tends to have higher

reproducibility when done in a head-to-head comparison of MOLLI, SASHA, and other
quantitative methods in phantom scans with global values (39). While previous studies were done
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in phantom studies and healthy volunteers, MOLLI TRUFI has shown to underperform in CS
patients with devices against SASHA variants and MOLLI FLASH.
By scrutinizing slice-based results, MOLLI TRUFI may not offer the best reproducibility for
diagnostic purposes when looking at specific regions like the basal or mid-cavity slices. Results of
an ANOVA test done on slice-based values called for a Tukey-Kramer test to identify the specific
cause for significant difference in means (Figure 7). A post hoc analysis was done on every
combinational pair of methods. Pairs with MOLLI TRUFI exceeded in qcrit and suggesting a
significant difference. This may suggest that MOLLI with a TRUFI readout may be the least
reliable in terms of repeatability whereas all other pairs did not show any significant difference.
From these results, MOLLI may not be preferred compared to other methods like SASHA for
monitoring disease progression or continual impact in patients as values may vary from scan to
scan between longer periods of time. While there is limited study on how readout may affect the
variance and reproducibility of a scan, FLASH may be preferred for consistent scanning.
Between initial and secondary visits, MOLLI demonstrated significant differences in both FLASH
and TRUFI readouts compared to SASHA on a slice-based level (Figure 7). As a result, MOLLI
may have higher variability and not be as reproducible in patients with devices as previous
literature has only been done in healthy participants (40). One study has found the native T1 testretest variability were higher in MOLLI compared to other inversion recovery methods (41). In
addition. Another study finds that MOLLI may have underlying variability in slice-based T1
mapping which may call for further insight when done on eighteen healthy volunteers and no
devices (42).
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2.8 Limitations
The following limitations in this study must be taken into consideration when interpreting these
results. First, this study was limited to a single clinic and single scanner. Results may vary between
scanners and clinics when used with the protocols developed in this study. Second, the study had
only five participants. One participant’s scans were excluded from further analysis due to severe
artifact effectively bringing the sample size to four. Although this was not a statistically powered
study, the small number of participants must be taken into consideration to frame the results for
further clinical use. Finally, amid the SARS-COV-2 pandemic, participants were not able to be
retested within the two-week time frame. Although one participant was scanned 64 days later, it
was determined that their condition had not changed significantly and would not affect the testretest scan in that regard.

2.9 Conclusion
The first aim of this thesis was to qualify which of the four scanning methods produced the best
image quality according to a pre-determined scale. The scale, which was previously used for
evaluating ECV quality, was modified to work with T1 values. Between the two sequences,
SASHA and MOLLI, SASHA had a higher percentage of scans deemed “fair”. MOLLI is well
documented to be dependent on MT, T2, and heart rate. These factors may have affected the slicebased results. MOLLI on the other hand outnumbered SASHA in every other category including
scans deemed “poor” (Figure 3) on a global scale. SASHA may produce less non-diagnostic or
“poor” scans with the trade-off of producing more “fair” rated regions. Taking a more in-depth
look at how readout method may affect IQS, the same general trends followed. It is important to
note that no TRUFI readout resulted in an excellent rating. From this, FLASH readouts coupled
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with a SASHA sequence may provide a higher percentage of scans for diagnostic use (Figure 3,
Figure 4).

Further, we wished to determine and quantify the reproducibility and variance of each method.
While initial global analysis did not provide any indication which method may have significant
differences between scans, slice-based analysis suggests MOLLI with a TRUFI readout (the most
commonly utilized T1 mapping variant of the four compared) may not be the most reproducible.
While this is not supported by current literature, further research is warranted to further justify the
use of MOLLI or a TRUFI readout in patients with sarcoidosis and devices compared to other
method and readout combinations. It is important to note the small sample size in this study as
results may change with increased participation. As for the variance between scans a TRUFI
readout may lead to more variability between scans (Figure 8). Using a post-hoc Tukey-Kramer
test revealed that MOLLI TRUFI had a notable variance and did not agree well with the other
methods. Regardless of sequence, the TRUFI readout may not be suitable for consistent use from
scan to scan.

3

Ancillary Analysis

Further quantitative analysis can be done with T1 post-contrast values, segmental considerations, and T2
values. Post contrast values generally allow for higher visual and quantitative contrast between healthy and
damaged myocardium. In addition, with T2 analysis, clinicians may better define inflammation and scar. A
recent study suggests that at least one T1-marker and T2-marker are needed to increase specificity in
identifying myocardial inflammation (34). While general practice takes images of the heart at three regions,
further segmental analysis is useful in isolating areas of the heart from artifact that may be useful in analysis.
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3.1 Post Contrast T1 Considerations
Following pre-contrast scans, participants were then injected with contrast and imaged again with
a MOLLI 4(1)3(1)2 scheme and a 2-parameter fit SASHA with TRUFI and FLASH readouts.
Evaluations of IQS and reproducibility of post-contrast scans were also performed.
SASHA and MOLLI scans were similar in IQS, although 3.03% of SASHA scanned regions were
deemed excellent (Figure 9).

Slice-Based Image Quality Score
Distribution in Post-Contrast Values
Non-diagnostic

Poor

Fair

Good

Excellent

120%
100%

3%

80%
60%

61%

64%

36%

36%

SASHA

MOLLI

40%
20%
0%

Figure 9. Image quality score distribution between SASHA and MOLLI scans of the heart. Slice-based scores were averaged
from segmental scoring in post-contrast scans.

When comparing the four methods separately, MOLLI FLASH and MOLLI TRUFI generally
outperformed the SASHA variants in the fair and good categories although only SASHA TRUFI
contained any excellent ratings at 4.17% of all SASHA TRUFI scans (n=24) (Figure 10).
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Slice-Based Image Quality Score Distribution
Among Four Methods in Post Contrast
Non-diagnostic

Poor

Fair

Good

Excellent

120%
100%

4%

80%

45%
54%
79%

60%

78%

40%
20%

55%

42%
21%

22%

MOLLI TRUFI

SASHA FLASH

0%
SASHA TRUFI

MOLLI FLASH

Figure 10. Distribution of slice-based image quality scores among the four methods: SASHA TRUFI, MOLLI TRUFI, SASHA
FLASH, and MOLLI FLASH in post-contrast scans.

There was no significant difference between global values in initial and secondary visits under a
paired t-test. Due to insufficient data, the SASHA FLASH method was not included. On average,
slice-based SASHA TRUFI T1-values showed significant difference between initial (491±264ms)
and secondary (530±145ms) visits (p-value=0.010). Under a one factor ANOVA test, global values
between the four methods shown no significant difference in post-contrast means (p-value=0.815).
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Global Post-Contrast ANOVA Test (p-value=0.815)
40
35

Average Δ T1 (ms)

30
25
20
15
10
5
0
-5

SASHA TRUFI

SASHA FLASH

MOLLI TRUFI

MOLLI FLASH

-10

Figure 11. Graphical representation of global ANOVA test done between SASHA TRUFI, SASHA FLASH, MOLLI TRUFI, and
MOLLI FLASH in post-contrast scans.

When considering the slice-based values, there was a significant difference in means between
groups (p-value=0.012) with a 95% confidence (Figure 12). Further post hoc analysis showed that
SASHA TRUFI+MOLLI TRUFI and MOLLI TRUFI+MOLLI FLASH have significant
difference (qcrit=3.91, df=23) (Figure 13).
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Slice-Based Post-Contrast ANOVA (p-value=0.012)
30

Average Δ T1 (ms)

20
10
0
SASHA TRUFI

SASHA FLASH

MOLLI TRUFI

MOLLI FLASH

-10
-20
-30

Figure 12. Graphical representation of slice-based ANOVA results between SASHA TRUFI, SASHA FLASH, MOLLI TRUFI,
and MOLLI FLASH in post-contrast scans.

Figure 13. Tukey-Kramer results showing variations between the four methods and their q-values for post-contrast T1-values.
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Looking at the CoV, 58.71% of post-contrast scans had higher variability globally when scanned
with MOLLI. Slice-based, 63.89% of scans with SASHA showed a higher CoV indicating higher
variability. Although not apparent when observing global values, looking at each slice shows that
SASHA has more variability post contrast. The contrast, which shorten T1, may amplify
SASHA’s well documented imprecision (39, 43).

3.2 Segmental Considerations
Each short-axis slice can be split into six segments for analysis according to the AHA 17-segment
model (38). In some cases, artifact may not be completely removed but some segment of the heart
may still be viable for diagnostic purposes, thus an exploratory analysis using segmental values
rather than slice-base or global values was performed.
In all SASHA scans, 98.81% of segments (n=252) were deemed diagnostic. 88.89% of segments
(n=216) among all MOLLI scans were deemed diagnostic (Figure 14). In SASHA scans, 98.61%
of segments (n=144) with TRUFI readouts were deemed diagnostic while 99.07% of segments
(n=108) with FLASH readouts had diagnostic value. In addition, 88.23% of MOLLI segments
(n=130) with TRUFI readouts were deemed diagnostic while 88.36% of segments (n=94) with
FLASH readouts were deemed diagnostic (Figure 15).
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Segmental Image Quality Score Distribution
Non-diagnostic
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Good

Excellent
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100%
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11%
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Figure 14. Image quality score distribution between SASHA and MOLLI segmental scans within the heart in pre-contrast values.
Results are a combination of all readouts.

Segmental Image Quality Score Distribution Among
Four Methods
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Figure 15. Distribution of segmental image quality scores among the four methods: SASHA TRUFI, MOLLI TRUFI, SASHA
FLASH, and MOLLI FLASH in pre-contrast values.
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In comparison of segmental values, MOLLI TRUFI demonstrated a significant difference in means
between initial (T1AVG=756±194ms) and secondary (T1AVG=828±175ms) visits (p-value=
0.0000086). Looking at the CoV of all segments among four participants, MOLLI showed higher
CoV when compared to SASHA. Out of 216 segments across four participants, 59.26% of
segments scanned with MOLLI had higher CoV. This indicates MOLLI having a higher variability
in segmental, pre-contrast T1 values. When comparing the different readouts, segments with a
TRUFI readout on average had a higher CoV when compared to FLASH.
Among segmental post-contrast values, 12% of MOLLI scans were deemed excellent compared
to only 10% of SASHA scans (Figure 16). When looking at each method individually, SASHA
FLASH had a lower percentage of segments deemed non-diagnostic at 1% in post-contrast values
(Figure 17).

Segmental Image Quality Score Distribution in
Post-Contrast
Non-diagnostic

Poor

Fair

Good

Excellent

120%
100%

10%

12%

48%

41%

29%

37%

11%
2%
SASHA

8%
2%
MOLLI

80%
60%
40%
20%
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Figure 16. Image quality score distribution between SASHA and MOLLI segmental scans within the heart in post-contrast
values.
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Segmental Image Quality Score Distribution Among
Four Methods
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Figure 17. Distribution of segmental image quality scores among the four methods: SASHA TRUFI, MOLLI TRUFI, SASHA
FLASH, and MOLLI FLASH in post-contrast values.

A one-factor ANOVA test was performed on all native segmental data. The test suggests there is significant
difference between the means of the T1 values on a segmental level. Further post hoc analysis via TukeyKramer test shows that SASHA TRUFI+MOLLI TRUFI, SASHA FLASH+MOLLI TRUFI, and MOLLI
TRUFI+MOLLI FLASH exceeded the critical value (qcrit=3.67, df=191) (Figure 18, Figure 19Figure
17).

Page 52 of 63

Segmental ANOVA (p-value=0.00000000749)

Average Δ T1 (ms)
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Figure 18. Graphical representation of segmental ANOVA results between SASHA TRUFI, SASHA FLASH, MOLLI TRUFI, and
MOLLI FLASH in pre-contrast scans.

Figure 19. Tukey-Kramer results showing variations between the four methods and their q-values for segmental, native T1values.
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In post-contrast analysis, an ANOVA test shows statistically significant difference among the four groups.
The post hoc test determined that MOLLI TRUFI+MOLLI FLASH were statistically different within the
groups (qcrit=3.67, df=151) (Figure 20). The post-contrast analysis can highlight the discrepancies
between scans and T1 values as the values decrease with contrast. This may have been enough to bring the
differences between MOLLI TRUFI and MOLLI GRE to the surface whereas pre-contrast values could not
show any significant differences.

Segmental ANOVA in Post-Contrast
(p-value=0.003)
25

Average Δ T1 (ms)

20
15
10
5
0
SASHA TRUFI

SASHA FLASH

MOLLI TRUFI

MOLLI FLASH

-5

Figure 20. Graphical representation of segmental ANOVA results between SASHA TRUFI, SASHA FLASH, MOLLI TRUFI, and
MOLLI FLASH in post-contrast scans.

In post contrast values, segments scanned with MOLLI showed higher CoV when compared to
SASHA. The higher CoV affected the basal and mid-cavity slices. This may be due to the
placement of the generator box of CIEDs near the area causing field inhomogeneities that highly
affect MOLLI sequences (39, 43-45).
When compared to a slice-based analysis, it was interesting to note that MOLLI FLASH’s mode
shifted to a score of 3 (fair) in segmental analysis. In both ANOVA results, MOLLI TRUFI
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contained significant statistical difference. This may indicate some trouble in using either the
MOLLI sequence or TRUFI readout when scanning participants, especially those with CS and
CIEDs.

3.3 T2 Considerations
In a slice-based analysis of T2 values among the available participants, those with a TRUFI readout
showed a significant change in means in participants four and five (p-values: 0.001 and 0.041
respectively). Scans done with a FLASH readout revealed no significant difference between initial
and secondary visits on a slice-based level.
In contrast, for initial and secondary segmental T2 values between visits, participants scanned with
a FLASH readout consistently showed significant change in means: p-values = 0.0004, not
available, 0.0002, and 0.0335 respectively for the four participants indicating a change in T2 means
between visits.
Under a one-factor ANOVA analysis, there was no suggestion that there are significant differences
between the means of the T2 delta values between the readout T2 map variants (Figure 21, Figure
22).

Overall, the MOLLI GRE protocol may be more reproducible and considered for T2

acquisition.
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Slice-Based ANOVA on T2 (p-value=0.462)
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Figure 21.Graphical representation of slice-based ANOVA results between TRUFI and FLASH readouts using T2 values.

Segmental ANOVA on T2 (p-value=0.995)
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Figure 22. Graphical representation of segmental ANOVA results between TRUFI and FLASH readouts using T2 values.

3.4 An In-Depth Look: A Head-to-Head Comparison
Due to the nature of this study, each protocol was optimized with every consecutive patient. After the first
participant’s initial and secondary scans, the protocol was slightly revised and optimized before being
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applied to the next participant and so on. As a result, it is reasonable to assume that the fifth participant was
scanned with the most refined protocol. The fifth participant was also the only participant to have all four
methods scanned and of diagnostic use. This may warrant an in-depth look at the scan data from a single
patient in a head-to-head comparison of all four methods. IQS scores for the fifth participant were compiled.
A paired t-test was applied to the initial and secondary visit T1 values. A single factor ANOVA test was
also done on the delta values of each method.

Segmental Image Quality Score Distribution in
Participant Five
Non-diagnostic

Poor

Fair

Good

Excellent

120%
100%
19%
80%
60%
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33%

39%

67%
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39%
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Figure 23. IQS scores for participant 5.

Only one segment was deemed non-diagnostic and removed from further statistical analysis. A paired t-test
was performed on all initial and secondary visits. A single factor ANOVA test was done and did not find
any statistically significant differences in the variances (p-value=0.663) (Figure 24). A Tukey-Kramer test
was still performed to compare every combination to see how each result affected the overall variance. The
only pairing that did not exceed the qcrit value was the pairing between MOLLI FLASH and SASHA FLASH
(Figure 25).
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Segmental ANOVA (p-value=0.663)
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Figure 24. ANOVA results for participant five.

Figure 25. Tukey-Kramer results showing variations between the four methods and their q-values in participant five

Looking at the isolated participant, it may indicate that a FLASH readout is more reliable compared to the
other combinations. Although a post-hoc analysis was not necessary, it revealed that MOLLI FLASH and
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SASHA FLASH were the only to have an agreeable mean. This may indicate that FLASH has lower
variance compared to the other methods (Figure 25).

3.5 Future Directions
CMR continues to display its benefits in non-invasive imaging for patients with sarcoidosis and
CIEDs. As these patients may be considered difficult to image, this study attempts to find a reliable
scanning sequence which is able to accurately define focal and diffuse fibrosis with consistent
results when repeated. Although inversion recovery methods like MOLLI are well documented,
exploring saturation recovery methods like SASHA may offer promising results in the presence of
diffuse fibrosis and artifact from devices. Future studies should further investigate the benefit of
using a saturation recovery method with a FLASH readout to assess sarcoidosis patients more
accurately for research and clinical management.
Although the type of scanning sequence is an important choice in regard to scanning patients with
challenging imaging circumstances, like sarcoidosis and CIEDs, the added complexity of readout
choice will also play a role in optimizing applications for clinical or research settings. While the
need for a non-biomarker method of monitoring or detecting sarcoidosis increases, CMR continues
to make strides to fulfill that role. CMR’s potential for non-invasive and non-ionizing imaging is
growing, and its integration of qualifiable and quantifiable data will prove useful in research and
clinical settings. By optimizing a CMR protocol for CS patients with devices, a key barrier is
overcome in obtaining clinically useful imaging for disease monitoring and diagnosis.
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